About
๐ป๐๐ข๐จ๐ฅ๐ฆ๐ ๐ฆ๐จ๐ ๐ ๐๐ฅ๐ฌ: This online course, "Certification Course in Biologics and Biosimilar Regulations," offers an in-depth exploration of the biopharmaceutical industry, focusing on the development, approval, and regulation of biologics and biosimilars. Starting with foundational knowledge about biopharmaceuticals and their classification, the course covers key topics such as the differences between chemical and biological drugs, naming conventions, and the global market landscape. Detailed modules discuss the production and regulation of monoclonal antibodies, the specifics of biological license applications, and the pathway for biosimilar development including strategic, manufacturing, and regulatory aspects. Additionally, the course examines the CQAs and CPPs essential for biopharmaceutical production. ๐ป๐๐๐ฆ๐ง ๐ข๐ ๐ง๐๐ ๐๐๐๐ง๐จ๐ฅ๐๐ฆ: 1. Introduction to biopharmaceuticals 2. Biopharmaceutical Classification 3. Chemical Drugs vs Biological Drugs 4. Principle of naming of biologic 5. Global biologics market 6. Recombinant proteins 7. Monoclonal antibodies vs polyclonal antibodies 8. Monoclonal antibodies 9. Biological license application 10. Abbreviated biosimilar application 11. Purple book 12. Vaccine development and approval process 13. Biosimilar development process 14. Strategic development of biosimilar 15. Biomanufacturing process 16. Studies required for approval of biosimilar 17. Regulatory requirements for biologics and biosimilar 18. Comparability of biosimilar 19. CQA and CPP for biopharmaceuticals ๐๐๐ฅ๐ง๐๐๐๐๐๐ง๐: ๐Receive a certificate upon successfully finishing this course ๐๐ข๐จ๐ฅ๐ฆ๐ ๐๐จ๐ฅ๐๐ง๐๐ข๐ก: โณ488 Minutes (8.13 Hours) ๐๐๐ก๐๐จ๐๐๐: ๐English ๐ฆ๐๐๐ ๐ฃ๐๐๐๐ ๐๐๐๐ฅ๐ก๐๐ก๐: ๐ This program is available to participants globally. โก๐๐ข๐ช๐ก๐ข๐๐๐๐๐๐ ๐ฅ๐๐ฆ๐ข๐จ๐ฅ๐๐๐ฆ: Participant can download all presentations/Reports ๐๐๐๐๐ฆ๐ฆ: ๐งYou will have 6 month (180days) access to the course
You can also join this program via the mobile app. Go to the app